Youth smoking in the United States has collapsed to historic lows, yet public health remains silent.

At the same time, adult smokers are moving in record numbers to safer nicotine products, signaling a profound market shift that regulators struggle to keep pace with.

In this episode of RegWatch, Dr. Chris Junker, Group Head of Life Sciences at British American Tobacco and former VP of Scientific & Regulatory Affairs at Reynolds American, discusses the FDA’s slow-moving PMTA process, the collapse of youth smoking, and the importance of scientific transparency in tobacco harm reduction.

From the unprecedented decline in youth smoking to the missed opportunities in public health, Junker provides a rare insider’s perspective on how science, regulation, and consumer behavior collide in America’s smokeless transition.

Only on RegWatch by RegulatorWatch.com.

Released: September 27, 2025
Produced by: Brent Stafford

This episode is supported by DEMAND VAPE.